Journals / Türk Mikrobiyoloji Cemiyeti Dergisi / 2022 / Cilt: 52 - Sayı: 2

Moraxella Bacteremia: Three Case Reports

Moraxella Bakteriyemisi: Üç Olgu Sunumu

Pages
139–143
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Gram-negative diplococci are rarely detected in blood samples, and when it is possible to warn the clinician at an early stage with careful direct examination, initiation of effective antibiotic therapy is life-saving.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Moraxella species are Gram-negative, oxidase and catalase-positive bacteria that can colonize mucosal surfaces.
📊
Key Findings & Data:M. catarrhalis is mostly resistant to beta-lactams due to its BRO-1 and BRO-2 genes.
💡
Conclusion & Impact:Conclusion: Gram-negative diplococci are rarely detected in blood samples, and when it is possible to warn the clinician at an early stage with careful direct examination, initiation of effective antibiotic therapy is life-saving.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Moraxella species are Gram-negative, oxidase and catalase-positive bacteria that can colonize mucosal surfaces. Moraxella catarrhalis, the most commonly detected species, is one of the most frequently isolated pathogens in childhood sinusitis, otitis media and chronic lower respiratory tract disease in adults. It can cause pneumonia in immunocompromised patients or those with chronic obstructive pulmonary disease (COPD). M. catarrhalis pneumonia is rarely associated with bacteremia. M. catarrhalis is mostly resistant to beta-lactams due to its BRO-1 and BRO-2 genes. We present three cases of Moraxella isolated from blood samples in our study. Methods: Cases in which Moraxella species were grown in blood cultures between December 2020 and October 2021 at Marmara University Pendik Training and Research Hospital were examined. Results: Moraxella catarrhalis caused bacteremia after pneumonia in two patients. Operated for breast cancer, A 68-year-old female patient with diabetes mellitus died on the 8th day despite antibiotic treatment, and a 3-year-old male patient without a chronic disease was discharged after 10 days of antibiotic treatment. Our third case, a 46-year-old female patient who was diagnosed with chronic lymphocytic leukemia and breast cancer and received chemotherapy, developed bacteremia due to Moraxella nonliquefaciens after sinusitis, and this patient recovered with antibiotic treatment. Conclusion: Gram-negative diplococci are rarely detected in blood samples, and when it is possible to warn the clinician at an early stage with careful direct examination, initiation of effective antibiotic therapy is life-saving.

Özet

Amaç: Moraxella türleri mukozal yüzeylerde kolonize olabilen Gram negatif, oksidaz ve katalaz pozitif bakterilerdir. En yaygın saptanan tür olan Moraxella catarrhalis çocukluk çağında sinüzit, orta kulak iltihabı ve erişkinlerde kronik alt solunum yolu hastalığında sıklıkla izole edilen patojenlerden biridir. İmmün sistemi baskılanmış hastalarda veya kronik obstrüktif akciğer hastalığı (KOAH) olanlarda pnömoniye neden olabilir. M. catarrhalis pnömonisi ender olarak bakteriyemi ile ilişkilidir. M. catarrhalis, BRO-1 ve BRO-2 genleri nedeniyle çoğunlukla beta laktamlara dirençlidir. Çalışmamızda, kan örneklerinden izole edilen üç Moraxella olgusu sunulmaktadır. Yöntem: Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi’nde 2020 Aralık ayı ile 2021 Ekim ayları arasında kan kültürlerinde Moraxella türleri üreyen olgular incelemeye alınmıştır. Bulgular: Moraxella catarrhalis’in etken olduğu iki hastada pnömoni sonrası bakteriyemi gelişmiştir. Meme kanseri nedeniyle opere olmuş, diabetes mellitus tanılı 68 yaşında kadın hasta antibiyotik tedavisine rağmen 8. günde kaybedilmiş, kronik bir hastalığı olmayan üç yaşındaki erkek hasta ise 10 gün antibiyotik tedavisi sonrası iyileşerek taburcu edilmiştir. Üçüncü olgumuz kronik lenfositer lösemi ve meme kanseri tanısıyla kemoterapi alan 46 yaşında kadın hasta olup, sinüzit sonrası Moraxella nonliquefaciens’e bağlı bakteriyemi gelişmiş bu hasta da antibiyotik tedavisi ile iyileşmiştir. Sonuç: Gram negatif diplokoklar kan örneklerinde ender olarak saptanmakta, dikkatli direk inceleme ile erken devrede klinisyeni uyarmak olası olduğunda etkili antibiyotik tedavisi başlanması yaşam kurtarıcı olmaktadır.

🔖

Cite This Article

DEMİRKOL, Ö., SARI, M., KARAHASAN, A., MARKU, M., ÇİMŞİT, N. Ç. (2022). Moraxella Bacteremia: Three Case Reports. Türk Mikrobiyoloji Cemiyeti Dergisi, Cilt: 52 - Sayı: 2, 139–143. https://ajindex.com/articles/635717

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Church DL. Aerobic Bacteriology. In: Leber LA (ed.). Clinical Microbiology Procedures Handbook. Washington: Springer-ASM, 2016
  2. Procop GW, Church DL, Hall GS, et al. Neisseria Species and Moraxella catarrhalis. In: Color Atlas and Textbook of Diagnostic Microbiology. Philadelphia: Wolters Kluwer Health, 2017:614-69
  3. Riedel S, Morse SA, Mietzner T, Miller S. Medical Microbiology. New York: Springer-Mc Graw Hill, 2019
  4. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. Philadelphia: Springer-Elsevier, 2016
  5. Funaki T, Inoue E, Miyairi I. Clinical characteristics of the patients with bacteremia due to Moraxella catarrhalis in children: a case-control study. BMC Infect Dis. 2016;16:73.
  6. Ariza-Prota MA, Pando-Sandoval A, García-Clemente M, Fole-Vázquez D, Casan P. Community-acquired Moraxella catarrhalis bacteremic pneumonia: Two case reports and review of the literature. Case Rep Pulmonol. 2016;2016:5134969.
  7. Correa-Martínez CL, Rauwolf KK, Schuler F, Füller M, Kampmeier S, Groll AH. Moraxella nonliquefaciens bloodstream infection and sepsis in a pediatric cancer patient: case report and literature review. BMC Infect Dis. 2019;19(1):836.
  8. Anezaki H, Terada N, Kawamura T, Kurai H. Moraxella catarrhalis bacteremic pneumonia. IDCases. 2020;19:e00712.
  9. Zaman S, Greene J. Moraxella bacteremia in cancer patients. Cureus. 2021;13(5):e15316.
  10. Shahani L, Tavakoli Tabasi S. Moraxella catarrhalis bacteraemia and prosthetic valve endocarditis. BMJ Case Rep. 2015;2015:bcr2014207368. https://doi.org/ 10.1136/bcr-2014-207368
  11. Ahmed A, Broides A, Givon-Lavi N, Peled N, Dagan R, Greenberg D. Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children. Pediatr Infect Dis J. 2008;27(5):459-61. https://doi.org/10.1097/INF.0b013e3181646d82